- Home
- MNPR vs FBIZ Comparison
MNPR vs FBIZ Comparison
Compare MNPR & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- FBIZ
- Stock Information
- Founded
- MNPR 2014
- FBIZ 1909
- Country
- MNPR United States
- FBIZ United States
- Employees
- MNPR N/A
- FBIZ N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- FBIZ Major Banks
- Sector
- MNPR Health Care
- FBIZ Finance
- Exchange
- MNPR Nasdaq
- FBIZ Nasdaq
- Market Cap
- MNPR 390.5M
- FBIZ 390.3M
- IPO Year
- MNPR 2019
- FBIZ N/A
- Fundamental
- Price
- MNPR $100.88
- FBIZ $50.64
- Analyst Decision
- MNPR Strong Buy
- FBIZ Buy
- Analyst Count
- MNPR 12
- FBIZ 3
- Target Price
- MNPR $89.82
- FBIZ $58.67
- AVG Volume (30 Days)
- MNPR 79.9K
- FBIZ 39.5K
- Earning Date
- MNPR 11-07-2025
- FBIZ 10-30-2025
- Dividend Yield
- MNPR N/A
- FBIZ 2.30%
- EPS Growth
- MNPR N/A
- FBIZ 22.50
- EPS
- MNPR N/A
- FBIZ 5.60
- Revenue
- MNPR N/A
- FBIZ $150,952,000.00
- Revenue This Year
- MNPR N/A
- FBIZ $17.98
- Revenue Next Year
- MNPR N/A
- FBIZ $8.16
- P/E Ratio
- MNPR N/A
- FBIZ $9.00
- Revenue Growth
- MNPR N/A
- FBIZ 8.24
- 52 Week Low
- MNPR $4.50
- FBIZ $41.50
- 52 Week High
- MNPR $105.00
- FBIZ $56.46
- Technical
- Relative Strength Index (RSI)
- MNPR 86.25
- FBIZ 48.42
- Support Level
- MNPR $92.27
- FBIZ $49.23
- Resistance Level
- MNPR $105.00
- FBIZ $51.94
- Average True Range (ATR)
- MNPR 7.25
- FBIZ 0.97
- MACD
- MNPR 1.88
- FBIZ -0.16
- Stochastic Oscillator
- MNPR 91.01
- FBIZ 50.62
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.